Literature DB >> 30583051

Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013.

Nicholas E Burr1, Richard Lord1, Mark A Hull1, Venkataraman Subramanian2.   

Abstract

BACKGROUND & AIMS: Gastrointestinal (GI) surgery is an important part of the treatment algorithm for patients with Crohn's disease (CD) that is complicated or does not respond to medical therapy. Cohort studies from Denmark and Canada have shown that the risk of primary surgery is decreasing but there is a lack of contemporary data on subsequent resections. We examined trends in first and second GI resections in patients with CD.
METHODS: We performed a retrospective cohort study using the United Kingdom primary care database ResearchOne, collecting data from patients with Crohn's disease from 1994 through 2013. We compared rates of first and second GI resections with etiological factors.
RESULTS: Among 3059 incident cases of CD, 13%, 21%, and 26% of the patients underwent surgical resections after 1, 5, and 10 years, respectively. Of patients with an initial resection, 20% required an additional operation when followed for 10 years after the initial resection. We found a significant reduction in first surgery, from 44% to 21% after 10 years of disease, from 1994 to 2003 (χ2 for trend, P < .05). There was a significant reduction in second resections, in a 10-year follow-up period, from 40% in 1994 to 17% in 2003 (χ2 for trend, P < .05). Duration of disease, younger age at diagnosis, smoking, and immunomodulator use were positively associated with first surgeries. Duration of disease was significantly associated with the risk of undergoing a second resection.
CONCLUSION: In a retrospective analysis of a United Kingdom primary care database, we observed a significant reduction in first and subsequent GI surgeries among patients with CD over the past 20 years in England.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; IBD; Operation; UK

Year:  2018        PMID: 30583051     DOI: 10.1016/j.cgh.2018.12.022

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  11 in total

1.  A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease.

Authors:  Parambir S Dulai; Vipul Jairath; Neeraj Narula; Emily Wong; Gursimran S Kochhar; Jean-Frederic Colombel; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

Review 2.  Pharmacological Prevention and Management of Postoperative Relapse in Pediatric Crohn's Disease.

Authors:  Anat Yerushalmy-Feler; Amit Assa
Journal:  Paediatr Drugs       Date:  2019-12       Impact factor: 3.022

Review 3.  Reducing Perioperative Risks of Surgery in Crohn's Disease.

Authors:  Wolfgang Reindl; Anne Kerstin Thomann; Christian Galata; Peter Kienle
Journal:  Visc Med       Date:  2019-11-12

4.  AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.

Authors:  Joseph D Feuerstein; Edith Y Ho; Eugenia Shmidt; Harminder Singh; Yngve Falck-Ytter; Shanaz Sultan; Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2021-06       Impact factor: 33.883

Review 5.  AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.

Authors:  Siddharth Singh; Deborah Proctor; Frank I Scott; Yngve Falck-Ytter; Joseph D Feuerstein
Journal:  Gastroenterology       Date:  2021-06       Impact factor: 33.883

6.  Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease.

Authors:  Anna Strömbeck; Anders Lasson; Hans Strid; Johanna Sundin; Per-Ove Stotzer; Magnus Simrén; Maria K Magnusson; Lena Öhman
Journal:  BMC Gastroenterol       Date:  2020-05-04       Impact factor: 3.067

Review 7.  Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn's Disease: A Meta-Analysis of Population-Based Cohorts.

Authors:  Lester Tsai; Christopher Ma; Parambir S Dulai; Larry J Prokop; Samuel Eisenstein; Sonia L Ramamoorthy; Brian G Feagan; Vipul Jairath; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-10-27       Impact factor: 13.576

8.  Development of a prognostic model for one-year surgery risk in Crohn's disease patients: A retrospective study.

Authors:  Jia-Yin Yao; Yi Jiang; Jia Ke; Yi Lu; Jun Hu; Min Zhi
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

9.  Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK.

Authors:  Rukshana Kapasi; Jackie Glatter; Christopher A Lamb; Austin G Acheson; Charles Andrews; Ian D Arnott; Kevin J Barrett; Graham Bell; Guaraang Bhatnagar; Stuart Bloom; Matthew James Brookes; Steven R Brown; Nicola Burch; Andy Burman; Kay Crook; Jr Fraser Cummings; Justin Davies; Anne Demick; Jenny Epstein; Omar Faiz; Roger Feakins; Melissa Fletcher; Vikki Garrick; Bruce Jaffray; Matthew Johnson; Katie Keetarut; Jimmy Limdi; Uchu Meade; Rafeeq Muhammed; Andrew Murdock; Nick Posford; Georgina Rowse; Ian Shaw; Anja St Clair Jones; Stuart Taylor; Sean Weaver; Lisa Younge; Antony Barney Hawthorne
Journal:  Frontline Gastroenterol       Date:  2019-07-24

10.  Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence.

Authors:  Mafalda Santiago; Fernando Magro; Luís Correia; Francisco Portela; Paula Ministro; Paula Lago; Eunice Trindade; Cláudia Camila Dias
Journal:  Clin Transl Gastroenterol       Date:  2020-09       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.